Clearside Biomedical, Inc. (CLSD) Social Stream

Clearside Biomedical, Inc. (CLSD): $1.30

-0.12 (-8.45%)

POWR Rating

Component Grades













Clearside Biomedical Inc (CLSD) Price Targets From Analysts

Use the tables below to see what analysts covering Clearside Biomedical Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-24 5 $19 $5 $12 $2.29 424.02%
2021-12-22 5 $17 $5 $10.4 $2.29 354.15%
2022-03-11 5 $17 $7 $10.8 $2.29 371.62%

The Trend in the Analyst Price Target

Over the past 46 weeks, CLSD's average price target has gone up $4.42.

Over the past 49 weeks, CLSD's average upside potential has been 163.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-10 5 8 3.5 6.38 2.56 149.22%
2021-06-05 5 9 3.5 6.63 2.89 129.41%
2021-08-01 5 18 5.0 11.40 4.92 131.71%
2021-09-04 5 18 5.0 11.60 6.60 75.76%
2021-11-24 5 19 5.0 12.00 4.04 197.03%

CLSD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations

Over the past 151 days, CLSD's average broker recommendation rating improved by 0.6.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Clearside Biomedical Inc's upside potential (average analyst target price relative to current price) is greater than 376.87% of them.
  • CLSD has a lower variance in analysts' estimates than -270.75% of all US stocks.
  • In terms of how Clearside Biomedical Inc fares relative to all US stocks, note that its average analyst price target is greater than 40.45% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, Clearside Biomedical Inc's number of analysts covering the stock is higher than 133.09% of them.

In the Pharmaceutical Products industry, CLNN, CKPT, and CINC are the three stocks most similar to Clearside Biomedical Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for CLSD? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4672 seconds.